Detalhe da pesquisa
1.
CRISPR/Cas9 targeting liposomes knocked down multidrug resistance proteins in brain endothelial cells as a model to predict potential pharmacoresistance.
Colloids Surf B Biointerfaces
; 222: 113103, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571980